As of 2025-07-09, the Relative Valuation of Samsung Pharm Co Ltd (001360.KS) is 5,360.90 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 1,681.00 KRW, the upside of Samsung Pharm Co Ltd based on Relative Valuation is 218.9%.
The range of the Relative Valuation is 4,550.09 - 6,332.10 KRW.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 21.3x | 19.6x |
| Forward P/E multiples | 15.3x - 18.5x | 16.5x |
| Fair Price | 4,550.09 - 6,332.10 | 5,360.90 |
| Upside | 170.7% - 276.7% | 218.9% |
| Date | P/E |
| 2025-07-04 | 5.77 |
| 2025-07-03 | 5.78 |
| 2025-07-02 | 5.74 |
| 2025-07-01 | 5.74 |
| 2025-06-30 | 5.77 |
| 2025-06-27 | 5.78 |
| 2025-06-26 | 5.84 |
| 2025-06-25 | 6.00 |
| 2025-06-24 | 6.04 |
| 2025-06-23 | 5.91 |
| 2025-06-20 | 6.13 |
| 2025-06-19 | 6.13 |
| 2025-06-18 | 6.25 |
| 2025-06-17 | 6.40 |
| 2025-06-16 | 6.49 |
| 2025-06-13 | 6.39 |
| 2025-06-12 | 6.34 |
| 2025-06-11 | 6.04 |
| 2025-06-10 | 5.55 |
| 2025-06-09 | 5.56 |
| 2025-06-05 | 5.49 |
| 2025-06-04 | 5.48 |
| 2025-06-02 | 5.43 |
| 2025-05-30 | 5.44 |
| 2025-05-29 | 5.42 |
| 2025-05-28 | 5.43 |
| 2025-05-27 | 5.44 |
| 2025-05-26 | 5.21 |
| 2025-05-23 | 5.17 |
| 2025-05-22 | 5.08 |
| 2025-05-21 | 4.96 |
| 2025-05-20 | 4.89 |
| 2025-05-19 | 4.87 |
| 2025-05-16 | 4.91 |
| 2025-05-15 | 5.02 |
| 2025-05-14 | 5.03 |
| 2025-05-13 | 5.02 |
| 2025-05-12 | 5.00 |
| 2025-05-09 | 4.98 |
| 2025-05-08 | 5.06 |
| 2025-05-07 | 5.03 |
| 2025-05-02 | 5.06 |
| 2025-04-30 | 5.05 |
| 2025-04-29 | 5.05 |
| 2025-04-28 | 5.02 |
| 2025-04-25 | 5.15 |
| 2025-04-24 | 5.12 |
| 2025-04-23 | 5.15 |
| 2025-04-22 | 5.15 |
| 2025-04-21 | 5.16 |